Table 1.
CHCC 2012 category | Causes and/or associated diseases | CHCC 2012 definition | Histopathology |
---|---|---|---|
ANCA-associated vasculitis |
Granulomatosis with polyangiitis (GPA) Microscopic polyangiitis (MPA) Eosinophilic granulomatosis with polyangiitis (EGPA) |
Necrotizing vasculitis with few or no immune deposits, predominantly affecting small vessels (i.e., capillaries, venules, arterioles, and small arteries); associated with ANCAs | Vasculitis of small-to-medium vessels in the skin, often with leukocytoclasia with or without granulomatous inflammation |
Immune complex vasculitis | Vasculitis with moderate-to-marked vessel wall deposits of immunoglobulin and/or complement components, predominantly affecting small vessels (i.e., capillaries, venules, arterioles, and small arteries) |
LCV of small vessels (mostly postcapillary venules, occasionally small veins or arterioles) |
|
Cryoglobulinemic Vasculitis (CV) |
Vasculitis with cryoglobulin immune deposits affecting small vessels (predominantly capillaries, venules, or arterioles); associated with serum cryoglobulins |
LCV of small vessels (postcapillary venules, small veins, or arterioles); associated with serum cryoglobulins (usually type II and type III) |
|
IgA-Vasculitis (Henoch–Schonlein purpura, HSP) |
Vasculitis with IgA1-dominant immune deposits, affecting small vessels (predominantly capillaries, venules, or arterioles) |
Leukocytoclastic IgA1-dominant vasculitis of mostly postcapillary venules and also veins or arterioles in the skin, with vascular IgA deposits | |
Hypocomplementemic Urticarial Vasculitis (anti-C1q vasculitis, HUV) |
Vasculitis accompanied by urticaria and hypocomplementemia, affecting small vessels (i.e., capillaries, venules, or arterioles) and associated with anti-C1q antibodies; common forms include glomerulonephritis, arthritis, obstructive pulmonary disease, and ocular inflammation |
Cutaneous LCV of mostly postcapillary venules with vascular deposits of immunoglobulins, and manifesting with lasting urticarial lesions; anti C1q antibodies may be present |
|
IgM/IgG immune complex vasculitis* | Vasculitis with IgM and/or IgG-dominant immune deposits, affecting small vessels (predominantly capillaries, venules, or arterioles) | Leukocytoclastic IgM and/or IgG-dominant vasculitis of mostly postcapillary venules and also veins or arterioles in the skin, with vascular deposits | |
Vasculitis associated with systemic diseases |
Rheumatoid arthritis Systemic lupus erythematosus Sjögren syndrome Sarcoidosis |
Vasculitis that is associated with and maybe secondary to (caused by) a systemic disease (e.g., rheumatoid vasculitis, SLE, sarcoid vasculitis, etc.); the name (diagnosis) should have a prefix term specifying the systemic disease (e.g., rheumatoid vasculitis, lupus vasculitis, etc.) | Cutaneous LCV as a component of systemic vasculitis; the type of cutaneous vasculitis (small vessel or medium vessel vasculitis) varies depending on the underlying systemic disease |
Vasculitis associated with probable etiology |
Drugs Infection Sepsis Neoplasms |
Vasculitis that is associated with a probable specific etiology, e.g., drug, infection, sepsis, neoplasm, etc |
Cutaneous LCV as a component of systemic vasculitis that is associated with a probable specific etiology, e.g., drug, sepsis, etc |
*Provisional category not included in the CHCC 2012